ZCH-4-2E8（2E8） is a novel anti-human CD19 monoclonal antibody generated in our laboratory. In previous studies,we have confirmed that 2E8-NCTD immunotoxin confers a clear role in targeting killing of CD19+ leukemic cells.
ZCH-4-2E8（简称2E8）是本实验室自行研制的抗人CD19单抗的新克隆,在先前的研究中,我们已证实2E8—NCTD免疫毒素对CD19+的白血病细胞具有明显的靶向杀伤作用。
参考来源 - 2E8·2,447,543篇论文数据，部分数据来源于NoteExpress
目的利用包裹阿霉素的血管内皮生长因子（VEGF）脂质体于体外靶向杀伤肿瘤血管内皮细胞。
ObjectiveTo evaluate the targeting ability and cytotoxicity of adriamycin liposomes conjugated with VEGF in vitro.
因此，靶向脂质体可以把包裹的抗癌药物专一地送给胃癌细胞，井杀伤它们。
Thus, the targeted liposomes can specifically deliver the antitumor drugs to gastric cancer cells and kill them.
我们取到癌细胞，添加靶向治疗(药物)，然后查看药物是否可以杀死或不可杀伤癌细胞。
We take the cancer cells, add the targeted therapy (drug) agent and show whether it can kill or not kill.
应用推荐